JPRN-jRCT1061230070尚未招募Unknown
The effects Of sodium-glucose coTransporter 2 inhibiTOR on fastIng Hepatic Insulin Clearance in type 2 diabetes - TOTTORI-HIC study
Okura Tsuyoshi0 个研究点目标入组 20 人开始时间: 2023年10月31日最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- >= 18age old 至 <= 75age old（—）
- 性别
- All
入选标准
- •1. Type 2 diabetes
- •2. HbA1c 6.5~10%
- •3. Diet therapy only, or Metformin, or DPP4 inhibitor
排除标准
- •1) Type 1 diabetes
- •2) Severe ketosis, diabetic coma within the past 24 weeks
- •3) Severe infection, operation, severe trauma
- •4) Pregnancy
- •5) Severe liver dysfunction
- •6) Severe renal dysfunction
- •7) Highper sensitivity to SGLT2 inhibitor
- •8) Urinary tract infection, genital infection
- •9) Malignancy
- •10) Administration history of SGLT2 inhibitor within 24 weeks
- •11) Administration history of insulin injection or sulfonylurea within 24 weeks
- •12) Patients who are considered not eligible for the study by the attending doctor due to medical reasons
研究者
相似试验
尚未招募
1 期
Sodium-Glucose Co-Transporter 2 inhibition prior to cardiac surgery and postoperative atrial fibrillation: a pilot randomised controlled trialCardiothoracic surgeryCardiovascular - Other cardiovascular diseasesSurgery - Other surgeryAtrial fibrillationACTRN12621000684820Flinders University16
尚未招募
1 期
Sodium-glucose co-transporter 2 inhibition prior to atrial fibrillation ablation: A pilot randomised controlled trialCardiovascular - Other cardiovascular diseasesAtrial fibrillationACTRN12621000685819Flinders University60
已完成
4 期
Effect of SGLT2 inhibitors on heart function in type 2 diabetic patients in south IndiaCTRI/2020/02/023195izams Institute of Medical Sciences
尚未招募
4 期
Effects of SGLT2 Inhibitor Therapy on Pancreatic and hepatic fat content in patients of Type 2 Diabetes MellitusCTRI/2019/08/020909ASTRA ZENECA PHARMACEUTICAL INDIA
进行中（未招募）
1 期
Sodium-glucose cotransporter-2 inhibition and renal oxygenation in type 1 diabetesMedDRA version: 21.1Level: LLTClassification code 10045228Term: Type I diabetes mellitusSystem Organ Class: 100000004861Type 1 diabetesEUCTR2019-004557-92-DKSteno Diabetes Center Copenhagen30